期刊文献+

构建雄黄诱导维甲酸耐药急性早幼粒细胞白血病NB4-R1细胞凋亡的蛋白质双向电泳图谱 被引量:2

Establishment of Two-dimensional Electrophoresis Proteomic Profiles of Retinoid Acid Resistant Human Acute Promyelocytic Leukemia NB4-R1 Cells with Apoptosis Induced by Realgar
下载PDF
导出
摘要 目的构建雄黄(四硫化四砷,tetra-arsenic tetra-sulfide,As4S4)诱导急性早幼粒细胞白血病(APL)维甲酸耐药细胞株NB4-R1细胞凋亡前后的差异蛋白质组表达谱。方法 首先应用MTT法、透射电镜、AnnexinV/PI双染法和激光共聚焦显微镜的一系列体外实验定性化和定量化雄黄诱导NB4-R1细胞凋亡的作用;然后应用高分辨二维双向电泳技术构建雄黄诱导维甲酸耐药细胞株NB4-R1凋亡前后的差异蛋白质组表达谱。结果 雄黄对NB4-R1细胞的生长抑制效应呈剂量和时间依赖性,雄黄作用24h半数抑制浓度(IC50)为(24.06±0.19)μmol/L,48h IC50为(9.50±0.13)μmol/L,72h IC50为(6.55±0.03)μmol/L;确定了25μmol/L雄黄作用24h和48h时分别为NB4-R1细胞凋亡主群的早期和凋亡晚期阶段;成功构建了雄黄诱导维甲酸耐药细胞株NB4-R1凋亡前后的差异蛋白质组表达谱,ImageMasterTM2D Platinum图像分析软件分析显示,未处理组(R0)、处理24h组(R24)和处理48h组(R48)的蛋白质组表达图谱分别平均含1069、975和893个点;R24与R0的匹配率为79.94%,R48与R0的匹配率为69.33%,R24与R48的匹配率为71.91%。结论 成功构建雄黄诱导维甲酸耐药细胞株NB4-R1凋亡前后的差异蛋白质组表达谱,为今后从整体上更好地理解雄黄诱导耐药APL细胞凋亡的蛋白质组传导网络以及筛选恶性血液肿瘤新型生物标志物和药物靶标方面奠定了基础。 Objective To establish the comparative proteomic profiles of retinoid acid(RA) resistant human acute promyelocytic leukemia(APL) NB4-R1 cells before and after apoptosis induced by realgar(tetra-arsenic tetra-sulfide,As4S4).Methods First a serial of assays were performed using MTT,transmission electron microscopy,Annexin V FITC/PI double-stain,flow cytometry and confocal laser scanning microscopy to qualitatively and quantitatively observe the in vitro apoptosis inducing effect of realgar on RA-resistant cells.Then the comparative proteomic profile before and after NB4-R1 apoptosis was established using high-resolution two-dimensional electrophoresis system.Results The inhibition effect of realgar on NB4-R1 cell growth was dose and time dependent.The 24-h 50% inhibiting concentration(IC50) was 24.06±0.19 μmol/L,and the 48-h IC50 9.50±0.13 μmol/L,and 72-h IC50 6.55±0.03 μmol/L,respectively.24 h and 48 h were the early and late phase of major NB4-R1 apoptotic cell populations induced by 25 μmol/L realgar respectively.Differential proteomic profiles before and after realgar induced NB4-R1 apoptosis were successfully established.Averagely 1 069,975 and 893 spots could be detected of the untreated group(R0),the 24-h treatment group(R24),and the 48-h treatment group(R48),respectively by ImageMasterTM 2D Platinum Software.The matching rate between R24 and R0 was 79.94% and that between R48 and R0 69.33%,and that between R24 and R48 71.91%.Conclusion Differential proteomic profiles of realgar induced NB4-R1 apoptosis were successfully established for the first time,which provided a basis for comprehensively understanding the signal transduction of realgar induced apoptosis in RA-resistant APL cells,also for screening new bio-markers and drug targets of hematopoietic malignant tumor.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2011年第3期391-396,共6页 Chinese Journal of Integrated Traditional and Western Medicine
基金 国家自然科学基金资助项目(No.30701133)
关键词 急性早幼粒细胞白血病 维甲酸耐药 NB4-R1细胞 雄黄(四硫化四砷) 凋亡 蛋白质组 acute promyelocytic leukemia retinoid acid resistance NB4-R1 cell realgar apoptosis proteome
  • 相关文献

参考文献11

  • 1Tallman MS, Andersen JW, Schiffer CA, et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Inter- group Protocol[J]. Blood, 2002,100(13) : 4298 -4302.
  • 2Fenaux P, Chevret S, Guerci A, et al. Long-term followup confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia[ J]. European APL group. Leukemia, 2000,14 (8) : 1371 - 1377.
  • 3Lu DP, Qiu JY, Jiang B, et al. Tetra-arsenic tetra-sulfide for treatment of acute promyelocytic leukemia : a pilot report [J]. Blood, 2002,99(9):3136 -3143.
  • 4复方黄黛片Ⅱ期临床试验协作组,钱林生,赵耀中.复方黄黛片治疗初诊急性早幼粒细胞白血病的Ⅱ期临床试验[J].中华血液学杂志,2006,27(12):801-804. 被引量:27
  • 5Lee SJ, Kim KH, Park JS, et al. Comparative analysis of cell surface proteins in chronic and acute leukemia cell lines[J]. Biochem Biophys Res Commun, 2007,357 (3) : 620 - 626.
  • 6Cui JW, Wang J, He K, et al. Two-dimensional electro- phoresis protein profiling as an analytical tool for human acute leukemia classification[J]. Electrophoresis, 2005,26 ( 1 ) :268-279.
  • 7Zheng PZ, Wang KK, Zhang QY, et al. Systems analysis of transcriptome and proteome in retinoic acid/arsenic triox-ide-induced cell differentiation/apoptosis of promyelocytic leukemia[J]. Proc Natl Acad Sci USA, 2005,102(21 ) : 7653-7658.
  • 8Harris MN, Ozpolat B, Abdi F, et al. Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic post-transcriptional control mechanisms in acute promyelocytic leukemia[J]. Blood, 2004,104(5) :1314-1323.
  • 9李薇,王冠军,崔久嵬,陈晓锋,张学敏.丁酸钠诱导NB4细胞凋亡的蛋白质组学研究[J].中华血液学杂志,2006,27(7):436-440. 被引量:4
  • 10Dong H, Ying T, Li T, et al. Comparative proteomic analysis of apoptosis induced by sodium selenite in human acute promyelocytic leukemia NB4 cells [ J ]. J Cell Biochem, 2006,98 (6) : 1495-1506.

二级参考文献14

共引文献29

同被引文献11

  • 1复方黄黛片Ⅱ期临床试验协作组,钱林生,赵耀中.复方黄黛片治疗初诊急性早幼粒细胞白血病的Ⅱ期临床试验[J].中华血液学杂志,2006,27(12):801-804. 被引量:27
  • 2陈楠楠,黄世林,向阳,张德杰,郭爱霞,陈爱萍.复方黄黛片含药灭活兔血清对NB_4细胞株的作用[J].中西医结合学报,2007,5(1):65-69. 被引量:13
  • 3Xin L, Wan-jun S, Zeng-jun L, et al. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center[ J]. Leuk Res, 2007,31(6) : 765 - 771.
  • 4Adbs L,Guerci A, Raffonx E, et al. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience[ J]. Blood,2010,115(9) ; 1690 -1696.
  • 5Naqai S, Nannya Y, Hangaishi A, et al. The race anddose of chemotherapy should be considered for optimizing maintenance therapy for acute promyelocytic leukemia[ J].Leuk Res, 2009, 33(10) : 1427 - 1429.
  • 6Awisati G, Lo-Coco F,Paoloni FP, et al. AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance [ J]. Blood, 2011,117(18) : 4716-4725.
  • 7Dai CW, Zhang GS,Shen JK, et al. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients [J]. Acta Haematol, 2009,121 (1) : 1 -8.
  • 80/Connell PA, Madureira PA, Berman JN, et al. Regulation of S100A10 by the PML-RAR-a oncoprotein [ J] . Blood, 2011,117(15) : 4095 -4105.
  • 9Chou WC, Dang CV. Acute promyelocytic leukemia : recent advances in therapy and molecular basis of response to arsenic therapies [J]. Curr Opin Hematol, 2005,12(1): 1-6.
  • 10三氧化二砷治疗难治复发急性早幼粒白血病39例临床观察[J].中国医师杂志,2008,10(3):413-414. 被引量:2

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部